On Friday, Shares of GNC Holdings Inc (NYSE:GNC), gained 5.35% to $29.75.
The GNC Third Quarter 2015 Earnings call webcast is now available on www.gnc.com via the Investor Relations section under “About GNC”. This replay will be available through November 27, 2015.
GNC Holdings, Inc. operates as a specialty retailer of health and wellness products. The company operates through three segments: Retail, Franchise, and Manufacturing/Wholesale. Its products comprise vitamins, minerals and herbal supplements, sports nutrition products, diet products, and other wellness products.
Shares of Platform Specialty Products Corp (NYSE:PAH), declined -3.69% to $10.44, during its last trading session.
OM Group, declared the successful completion of its agreement to be attained by funds managed by associates of Apollo Global Administration, LLC, in partnership with an associate of Platform Specialty Products Corporation (PAH).
On June 1, 2015, OM Group, the Apollo Funds and Platform declared that they had reached a merger agreement whereby OM Group stockholders were entitled to receive $34.00 per share in cash, representing a 28% premium above OM Group’s closing share price on May 29, 2015, the last trading day preceding to the declaration of the merger.
As a result of the transactions, OM Group has become a privately-held partner of the Apollo Funds, and OM Group’s common stock is no longer trading on the New York Stock Exchange, effective recently. Right Away following the completion of the merger transaction, Platform has attained OM Group’s Electronic Chemicals and Photomasks businesses, not taking into account certain assets in Malaysia, which Platform has reached a contract to acquire from associates of the Apollo Funds in a separate transaction that is predictable to close in January 2016, subject to customary closing conditions. The remaining three OM Group businesses, counting the Magnetic Technologies, Battery Technologies and Advanced Organics businesses, will be retained by the Apollo Funds.
Platform Specialty Products Corporation produces and sells specialty chemical products in the Americas, Asia, and Europe. The company’s Performance Materials segment manufactures and markets plating products that are used to plate holes; final finishes, which are used on printed circuit boards; circuit formation products to promote adhesion and form circuit patterns; oxides that are used in the fabrication of multilayer circuit boards; and pre-treatment and cleaning solutions.
Finally, Shares of McKesson Corporation (NYSE:MCK), ended its last trade with -4.00% loss, and closed at $178.80.
McKesson Corporation, declared a regular dividend of twenty-eight cents per share on Common Stock. The dividend will be payable on January 4, 2016, to stockholders of record on December 1, 2015.
McKesson Corporation, presently ranked 11th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson assists its customers improve their financial, operational, and clinical performance with solutions that comprise pharmaceutical and medical-surgical supply administration, healthcare information technology, and business and clinical services.
McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions.